Synthesis and Evaluation of Selected Key Methyl Ether Derivatives of Vancomycin Aglycon
- 20 September 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 53 (19), 7229-7235
- https://doi.org/10.1021/jm100946e
Abstract
A select series of methyl ether derivatives of vancomcyin aglycon were prepared and examined for antimicrobial activity against vancomycin-sensitive Staphylococcus aureus and vancomycin-resistant Enterococci faecalis as well as their binding affinity for d-Ala-d-Ala and d-Ala-d-Lac. The intent of the study was to elucidate the role selected key methyl groups may play in the improvement of the in vitro antimicrobial profile of the tetra methyl ether derivative of vancomycin aglycon against vancomycin-resistant Enterococci faecalis previously reported. In these studies, methodology for selective derivatization of the A-, B-, and D-ring was developed that defines the relative reactivity of the four phenols of vancomycin aglycon, providing a foundation for future efforts for site-directed modification of the vancomycin aglycon core.Keywords
This publication has 7 references indexed in Scilit:
- Vancomycin analogs: Seeking improved binding of d-Ala-d-Ala and d-Ala-d-Lac peptides by side-chain and backbone modificationsBioorganic & Medicinal Chemistry, 2009
- Vancomycin resistance: Modeling backbone variants with d-Ala-d-Ala and d-Ala-d-Lac peptidesBioorganic & Medicinal Chemistry Letters, 2008
- Synthesis and evaluation of methyl ether derivatives of the vancomycin, teicoplanin, and ristocetin aglycon methyl estersBioorganic & Medicinal Chemistry Letters, 2003
- Partitioning the Loss in Vancomycin Binding Affinity for d-Ala-d-Lac into Lost H-Bond and Repulsive Lone Pair ContributionsJournal of the American Chemical Society, 2003
- Vancomycin analogues active against vanA-resistant strains inhibit bacterial transglycosylase without binding substrateProceedings of the National Academy of Sciences, 2003
- Synthesis and evaluation of vancomycin and vancomycin aglycon analogues that bear modifications in the residue 3 asparagineBioorganic & Medicinal Chemistry Letters, 2002
- Vancomycin Derivatives That Inhibit Peptidoglycan Biosynthesis Without Binding d -Ala- d -AlaScience, 1999